The effect of genetic diversity on angiogenesis

Experimental Cell Research

Volumn 312, Issue 5, 2006, Pages 561-574

  Rogers, Michael S ^a   D'Amato, Robert J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

AngFq; Angiopoietin; AngVq; Endostatin; HIF1alpha; Mmtg; Thrombospondin; VEGF receptor

Indexed keywords

ANGIOPOIETIN; COLLAGEN; CYTOKINE; ENDOSTATIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; LEPTIN; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTHRITIS; ATHEROSCLEROSIS; CANCER; CANCER STAGING; CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; EMBRYO DEVELOPMENT; ENDOMETRIOSIS; FOOD INTAKE; GENE ACTIVITY; GENE CONTROL; GENE DISRUPTION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; NONHUMAN; PHENOTYPE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; QUANTITATIVE TRAIT LOCUS; REPORTER GENE; RETROLENTAL FIBROPLASIA; REVIEW; SARCOIDOSIS; SPONTANEOUS ABORTION; TELANGIECTASIA; TUMOR GROWTH; UPREGULATION; VASCULAR DISEASE;

ANIMALIA; MAMMALIA;

EID: 33344479399     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.10.021     Document Type: Review

References (116)

1. B.L. Loeys, J. Chen, E.R. Neptune, D.P. Judge, M. Podowski, T. Holm, J. Meyers, C.C. Leitch, N. Katsanis, N. Sharifi, F.L. Xu, L.A. Myers, P.J. Spevak, D.E. Cameron, J. De Backer, J. Hellemans, Y. Chen, E.C. Davis, C.L. Webb, W. Kress, P. Coucke, D.B. Rifkin, A.M. De Paepe, and H.C. Dietz A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 Nat. Genet. 37 2005 275 281
2. J. Rak, J.L. Yu, G. Klement, and R.S. Kerbel Oncogenes and angiogenesis: signaling three-dimensional tumor growth J. Investig. Dermatol. Symp. Proc. 5 2000 24 33
3. A.L. Sertie, V. Sossi, A.A. Camargo, M. Zatz, C. Brahe, and M.R. Passos-Bueno Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome) Hum. Mol. Genet. 9 2000 2051 2058
4. N. Fukai, L. Eklund, A.G. Marneros, S.P. Oh, D.R. Keene, L. Tamarkin, M. Niemela, M. Ilves, E. Li, T. Pihlajaniemi, and B.R. Olsen Lack of collagen XVIII/endostatin results in eye abnormalities EMBO J. 21 2002 1535 1544
5. T.S. Zorick, Z. Mustacchi, S.Y. Bando, M. Zatz, C.A. Moreira-Filho, B. Olsen, and M.R. Passos-Bueno High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours Eur. J. Hum. Genet. 9 2001 811 814
6. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
7. P. Carmeliet, Y.S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, I. Cornelissen, E. Ehler, V.V. Kakkar, I. Stalmans, V. Mattot, J.C. Perriard, M. Dewerchin, W. Flameng, A. Nagy, F. Lupu, L. Moons, D. Collen, P.A. D'Amore, and D.T. Shima Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat. Med. 5 1999 495 502
8. I.J. Brogan, N. Khan, K. Isaac, J.A. Hutchinson, V. Pravica, and I.V. Hutchinson Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene Hum. Immunol. 60 1999 1245 1249
9. W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer-Pietsch, and E. Pilger A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J. Vasc. Res. 37 2000 443 448
10. A. Stevens, J. Soden, P.E. Brenchley, S. Ralph, and D.W. Ray Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter Cancer Res. 63 2003 812 816
11. C.J. Watson, N.J. Webb, M.J. Bottomley, and P.E. Brenchley Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 2000 1232 1235
12. T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe, K. Inukai, I. Inoue, and S. Katayama A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 2002 1635 1639
13. L. Boiardi, B. Casali, D. Nicoli, E. Farnetti, Q. Chen, P. Macchioni, M.G. Catanoso, L. Pulsatelli, R. Meliconi, and C. Salvarani Vascular endothelial growth factor gene polymorphisms in giant cell arteritis J. Rheumatol. 30 2003 2160 2164
14. W.M. Howell, A.C. Bateman, S.J. Turner, A. Collins, and J.M. Theaker Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma Genes Immun. 3 2002 229 232
15. S.W. Han, G.W. Kim, J.S. Seo, S.J. Kim, K.H. Sa, J.Y. Park, J. Lee, S.Y. Kim, J.J. Goronzy, C.M. Weyand, and Y.M. Kang VEGF gene polymorphisms and susceptibility to rheumatoid arthritis Rheumatology (Oxford) 43 2004 1173 1177
16. H. Lu, X.O. Shu, Y. Cui, N. Kataoka, W. Wen, Q. Cai, Z.X. Ruan, Y.T. Gao, and W. Zheng Association of genetic polymorphisms in the VEGF gene with breast cancer survival Cancer Res. 65 2005 5015 5019
17. C.C. Szeto, K.M. Chow, P. Poon, C.Y. Szeto, T.Y. Wong, and P.K. Li Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients Kidney Int. 65 2004 1947 1955
18. M. Bhanoori, K. Arvind Babu, N.G. Pavankumar Reddy, K. Lakshmi Rao, K. Zondervan, M. Deenadayal, S. Kennedy, and S. Shivaji The vascular endothelial growth factor (VEGF) +405G > C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study Hum. Reprod. 20 2005 1844 1849
19. S.J. Prior, J.M. Hagberg, D.A. Phares, M.D. Brown, L. Fairfull, R.E. Ferrell, and S.M. Roth Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption Physiol. Genomics 15 2003 20 26
20. K. Tanimoto, K. Yoshiga, H. Eguchi, M. Kaneyasu, K. Ukon, T. Kumazaki, N. Oue, W. Yasui, K. Imai, K. Nakachi, L. Poellinger, and M. Nishiyama Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance Carcinogenesis 24 2003 1779 1783
21. T. Kuwai, Y. Kitadai, S. Tanaka, T. Kuroda, T. Ochiumi, S. Matsumura, N. Oue, W. Yasui, M. Kaneyasu, K. Tanimoto, M. Nishiyama, and K. Chayama Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma Oncol. Rep. 12 2004 1033 1037
22. M.J. Percy, S.M. Mooney, M.F. McMullin, A. Flores, T.R. Lappin, and F.S. Lee A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation Mol. Cancer 2 2003 31
23. H. Kariyazono, T. Ohno, V. Khajoee, K. Ihara, K. Kusuhara, N. Kinukawa, Y. Mizuno, and T. Hara Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease Pediatr. Res. 56 2004 953 959
24. O. Menzel, R.C. Bekkeheien, A. Reymond, N. Fukai, E. Boye, G. Kosztolanyi, S. Aftimos, S. Deutsch, H.S. Scott, B.R. Olsen, S.E. Antonarakis, and M. Guipponi Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin Hum. Mutat. 23 2004 77 84
25. P. Iughetti, O. Suzuki, P.H. Godoi, V.A. Alves, A.L. Sertie, T. Zorick, F. Soares, A. Camargo, E.S. Moreira, C. di Loreto, C.A. Moreira-Filho, A. Simpson, G. Oliva, and M.R. Passos-Bueno A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma Cancer Res. 61 2001 7375 7378
26. H.C. Li, Q.Y. Cai, E.T. Shinohara, H. Cai, C. Cao, Z.F. Wang, M. Teng, W. Zheng, and B. Lu Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate cancer Dis. Markers 21 2005 37 41
27. T.C. Liu, C.T. Peng, S.F. Lin, C.S. Chang, T.P. Chen, and J.G. Chang Association of endostatin D104N with leukemia Kaohsiung J. Med. Sci. 19 2003 1 5
28. M.M. Ortega, H. Nascimento, F.F. Costa, M.T. Teori, and C.S. Lima A polymorphism in the angiogenesis inhibitor, endostatin, in multiple myeloma Leuk. Res. 27 2003 93 94
29. S. Shiozawa, K. Komai, H. Kawasaki, M. Sato, M. Nakatsukasa, T. Nakashima, R. Okayama, and C. Sakai The molecular genetics of rheumatoid arthritis disease gene Nippon Rinsho 60 2002 2269 2275
30. E.G. Ward, K. Grosios, A.F. Markham, and P.F. Jones Genomic structures of the human angiopoietins show polymorphism in angiopoietin-2 Cytogenet. Cell Genet. 94 2001 147 154
31. E.J. Topol, J. McCarthy, S. Gabriel, D.J. Moliterno, W.J. Rogers, L.K. Newby, M. Freedman, J. Metivier, R. Cannata, C.J. O'Donnell, K. Kottke-Marchant, G. Murugesan, E.F. Plow, O. Stenina, and G.Q. Daley Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction Circulation 104 2001 2641 2644
32. O.I. Stenina, T.V. Byzova, J.C. Adams, J.J. McCarthy, E.J. Topol, and E.F. Plow Coronary artery disease and the thrombospondin single nucleotide polymorphisms Int. J. Biochem. Cell Biol. 36 2004 1013 1030
33. S.Z. Rittersma, S.M. Boekholdt, K.T. Koch, R. Geuzebroek, M. Bax, C.E. Schotborgh, H. Eckmann, R.J. Peters, J.J. Piek, J.G. Tijssen, P.H. Reitsma, and R.J. de Winter Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosis Am. J. Med. 116 2004 499 500
34. X.N. Liu, L. Song, D.W. Wang, Y.H. Liao, A.Q. Ma, Z.M. Zhu, B.R. Zhao, J.Z. Zhao, and R.T. Hui Correlation of thrombospondin-1 G1678A polymorphism to stroke: a study in Chinese population Zhonghua Yixue Zazhi 84 2004 1959 1962
35. 2+ binding J. Biol. Chem. 279 2004 51915 51922
36. 2+-binding repeats J. Biol. Chem. 278 2003 8929 8934
37. N.V. Narizhneva, V.J. Byers-Ward, M.J. Quinn, F.J. Zidar, E.F. Plow, E.J. Topol, and T.V. Byzova Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction J. Biol. Chem. 279 2004 21651 21657
38. O.I. Stenina, S.Y. Desai, I. Krukovets, K. Kight, D. Janigro, E.J. Topol, and E.F. Plow Thrombospondin-4 and its variants: expression and differential effects on endothelial cells Circulation 108 2003 1514 1519
39. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
40. B. Anand-Apte, M.S. Pepper, E. Voest, R. Montesano, B. Olsen, G. Murphy, S.S. Apte, and B. Zetter Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3 Invest. Ophthalmol. Visual Sci. 38 1997 817 823
41. J.H. Qi, Q. Ebrahem, N. Moore, G. Murphy, L. Claesson-Welsh, M. Bond, A. Baker, and B. Anand-Apte A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Nat. Med. 9 2003 407 415
42. A. Loktionov Common gene polymorphisms, cancer progression and prognosis Cancer Lett. 208 2004 1 33
43. V. Vasku, A. Vasku, S. Tschoplova, L. Izakovicova Holla, V. Semradova, and J. Vacha Genotype association of C(-735)T polymorphism in matrix metalloproteinase 2 gene with G(8002)A endothelin 1 gene with plaque psoriasis Dermatology 204 2002 262 265
44. A. Luttun, M. Dewerchin, D. Collen, and P. Carmeliet The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies Curr. Atheroscler. Rep. 2 2000 407 416
45. S.P. Balasubramanian, N.J. Brown, and M.W. Reed Role of genetic polymorphisms in tumour angiogenesis Br. J. Cancer 87 2002 1057 1065
46. V. Pravica, A. Asderakis, C. Perrey, A. Hajeer, P.J. Sinnott, and I.V. Hutchinson In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene Eur. J. Immunogenet. 26 1999 1 3
47. A. Saha, A. Dhir, A. Ranjan, V. Gupta, N. Bairwa, and R. Bamezai Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer Immunogenetics 57 2005 165 171
48. S.L. McCarron, S. Edwards, P.R. Evans, R. Gibbs, D.P. Dearnaley, A. Dowe, C. Southgate, D.F. Easton, R.A. Eeles, and W.M. Howell Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res. 62 2002 3369 3372
49. K.C. Smith, A.C. Bateman, H.M. Fussell, and W.M. Howell Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur. J. Immunogenet. 31 2004 167 173
50. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott, and I.V. Hutchinson An investigation of polymorphism in the interleukin-10 gene promoter Eur. J. Immunogenet. 24 1997 1 8
51. W.M. Howell, S.J. Turner, A.C. Bateman, and J.M. Theaker IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma Genes Immun. 2 2001 25 31
52. J.S. Silvestre, Z. Mallat, M. Duriez, R. Tamarat, M.F. Bureau, D. Scherman, N. Duverger, D. Branellec, A. Tedgui, and B.I. Levy Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb Circ. Res. 87 2000 448 452
53. S. Huang, K. Xie, C.D. Bucana, S.E. Ullrich, and M. Bar-Eli Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis Clin. Cancer Res. 2 1996 1969 1979
54. R. Ribeiro, A. Vasconcelos, S. Costa, D. Pinto, A. Morais, J. Oliveira, F. Lobo, C. Lopes, and R. Medeiros Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease Prostate 59 2004 268 274
55. M.Z. Haider, L.V. Devarajan, M. Al-Essa, and H. Kumar A C597->A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants J. Biomed. Sci. 9 2002 365 370
56. S.J. Talks, N. Ebenezer, P. Hykin, G. Adams, F. Yang, E. Schulenberg, K. Gregory-Evans, and C.Y. Gregory-Evans De novo mutations in the 5′ regulatory region of the Norrie disease gene in retinopathy of prematurity J. Med. Genet. 38 2001 E46
57. M. Ziche, and L. Morbidelli Nitric oxide and angiogenesis J. Neuro-Oncol. 50 2000 139 148
58. E.K. Riener, L.A. Hefler, C. Grimm, A. Galid, R. Zeillinger, D. Tong-Cacsire, G. Gitsch, S. Leodolter, and C.B. Tempfer Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer Gynecol. Oncol. 93 2004 686 690
59. R. Medeiros, R. Soares, A. Vasconcelos, F. Schmitt, and C. Lopes Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer Angiogenesis 7 2004 53 58
60. C.B. Ambrosone, C. Sweeney, B.F. Coles, P.A. Thompson, G.Y. McClure, S. Korourian, M.Y. Fares, A. Stone, F.F. Kadlubar, and L.F. Hutchins Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer Cancer Res. 61 2001 7130 7135
61. G. Bergers, K. Javaherian, K.M. Lo, J. Folkman, and D. Hanahan Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 1999 808 812
62. T. Le Voyer, J. Rouse, Z. Lu, T. Lifsted, M. Williams, and K.W. Hunter Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density Genomics 74 2001 253 261
63. S.J. Hsu, H. Nagase, and A. Balmain Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity Genome 47 2004 931 946
64. N. Tripodis, and P. Demant Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry Cancer Res. 63 2003 125 131
65. S. Lentzsch, M.S. Rogers, R. LeBlanc, A.E. Birsner, J.H. Shah, A.M. Treston, K.C. Anderson, and R.J. D'Amato S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice Cancer Res. 62 2002 2300 2305
66. Y. Shaked, F. Bertolini, S. Man, M.S. Rogers, D. Cervi, T. Foutz, K. Rawn, D. Voskas, D.J. Dumont, Y. Ben-David, J. Lawler, J. Henkin, J. Huber, D.J. Hicklin, R.J. D'Amato, and R.S. Kerbel Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; implications for cellular surrogate marker analysis of antiangiogenesis Cancer Cell 7 2005 101 111
67. M.S. Rogers, R.M. Rohan, A.E. Birsner, and R.J. D'Amato Genetic loci that control vascular endothelial growth factor-induced angiogenesis FASEB J. 17 2003 2112 2114
68. M.S. Rogers, R.M. Rohan, A.E. Birsner, and R.J. D'Amato Genetic loci that control the angiogenic response to basic fibroblast growth factor FASEB J. 18 2004 1050 1059
69. Z.B. Zeng Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci Proc. Natl. Acad. Sci. U. S. A. 90 1993 10972 10976
70. Z.B. Zeng Precision mapping of quantitative trait loci Genetics 136 1994 1457 1468
71. V.V. Colinayo, J.H. Qiao, X. Wang, K.L. Krass, E. Schadt, A.J. Lusis, and T.A. Drake Genetic loci for diet-induced atherosclerotic lesions and plasma lipids in mice Mamm. Genome 14 2003 464 471
72. M.T. Pletcher, P. McClurg, S. Batalov, A.I. Su, S.W. Barnes, E. Lagler, R. Korstanje, X. Wang, D. Nusskern, M.A. Bogue, R.J. Mural, B. Paigen, and T. Wiltshire Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse PLoS Biol. 2 2004 e393
73. S.A. Abdalla, U. Cymerman, D. Rushlow, N. Chen, G.P. Stoeber, E.G. Lemire, and M. Letarte Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia Hum. Mutat. 25 2005 320 321
74. M. Vikkula, L.M. Boon, K.L. Carraway III, J.T. Calvert, A.J. Diamonti, B. Goumnerov, K.A. Pasyk, D.A. Marchuk, M.L. Warman, L.C. Cantley, J.B. Mulliken, and B.R. Olsen Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2 Cell 87 1996 1181 1190
75. J.T. Calvert, T.J. Riney, C.D. Kontos, E.H. Cha, V.G. Prieto, C.R. Shea, J.N. Berg, N.C. Nevin, S.A. Simpson, K.A. Pasyk, M.C. Speer, K.G. Peters, and D.A. Marchuk Allelic and locus heterogeneity in inherited venous malformations Hum. Mol. Genet. 8 1999 1279 1289
76. S. Laberge-le Couteulx, H.H. Jung, P. Labauge, J.P. Houtteville, C. Lescoat, M. Cecillon, E. Marechal, A. Joutel, J.F. Bach, and E. Tournier-Lasserve Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas Nat. Genet. 23 1999 189 193
77. P. Brouillard, L.M. Boon, J.B. Mulliken, O. Enjolras, M. Ghassibe, M.L. Warman, O.T. Tan, B.R. Olsen, and M. Vikkula Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (" glomangiomas") Am. J. Hum. Genet. 70 2002 866 874
78. P. Brouillard, B.R. Olsen, and M. Vikkula High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22 Genomics 67 2000 96 101
79. G.C. Black, R. Perveen, R. Bonshek, M. Cahill, J. Clayton-Smith, I.C. Lloyd, and D. McLeod Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis Hum. Mol. Genet. 8 1999 2031 2035
80. B.H. Weber, G. Vogt, R.C. Pruett, H. Stohr, and U. Felbor Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy Nat. Genet. 8 1994 352 356
81. J. Robitaille, M.L. MacDonald, A. Kaykas, L.C. Sheldahl, J. Zeisler, M.P. Dube, L.H. Zhang, R.R. Singaraja, D.L. Guernsey, B. Zheng, L.F. Siebert, A. Hoskin-Mott, M.T. Trese, S.N. Pimstone, B.S. Shastry, R.T. Moon, M.R. Hayden, Y.P. Goldberg, and M.E. Samuels Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy Nat. Genet. 32 2002 326 330
82. X.L. Tian, R. Kadaba, S.A. You, M. Liu, A.A. Timur, L. Yang, Q. Chen, P. Szafranski, S. Rao, L. Wu, D.E. Housman, P.E. DiCorleto, D.J. Driscoll, J. Borrow, and Q. Wang Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome Nature 427 2004 640 645
83. M.J. Karkkainen, R.E. Ferrell, E.C. Lawrence, M.A. Kimak, K.L. Levinson, M.A. McTigue, K. Alitalo, and D.N. Finegold Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema Nat. Genet. 25 2000 153 159
84. Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, H. Zientek, J. Rogozinska-Szczepka, B. Utracka-Hutka, G. Hallmans, and A. Forsti Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin. Cancer Res. 11 2005 3647 3653
85. M.I. Koukourakis, D. Papazoglou, A. Giatromanolaki, G. Bougioukas, E. Maltezos, and E. Siviridis VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer Lung Cancer 46 2004 293 298
86. M. Shahbazi, A.A. Fryer, V. Pravica, I.J. Brogan, H.M. Ramsay, I.V. Hutchinson, and P.N. Harden Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J. Am. Soc. Nephrol. 13 2002 260 264
87. W.M. Howell, S. Ali, M.J. Rose-Zerilli, and S. Ye VEGF polymorphisms and severity of atherosclerosis J. Med. Genet. 42 2005 485 490
88. F.B. Lemos, W.M. Mol, J.I. Roodnat, A. Uitterlinden, J.N. Ijzermans, W. Weimar, and C.C. Baan The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation Transplantation 79 2005 1221 1225
89. R. Del Bo, M. Scarlato, S. Ghezzi, F. Martinelli Boneschi, C. Fenoglio, S. Galbiati, R. Virgilio, D. Galimberti, G. Galimberti, M. Crimi, C. Ferrarese, E. Scarpini, N. Bresolin, and G.P. Comi Vascular endothelial growth factor gene variability is associated with increased risk for AD Ann. Neurol. 57 2005 373 380
90. E.J. Kim, P. Jeong, C. Quan, J. Kim, S.C. Bae, S.J. Yoon, J.W. Kang, S.C. Lee, J. Jun Wee, and W.J. Kim Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer Urology 65 2005 70 75
91. T. Awata, S. Kurihara, N. Takata, T. Neda, H. Iizuka, T. Ohkubo, M. Osaki, M. Watanabe, Y. Nakashima, K. Inukai, I. Inoue, I. Kawasaki, K. Mori, S. Yoneya, and S. Katayama Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes Biochem. Biophys. Res. Commun. 333 2005 679 685
92. G. Gillerot, E. Goffin, C. Michel, P. Evenepoel, W.V. Biesen, M. Tintillier, P. Stenvinkel, O. Heimburger, B. Lindholm, L. Nordfors, A. Robert, and O. Devuyst Genetic and clinical factors influence the baseline permeability of the peritoneal membrane Kidney Int. 67 2005 2477 2487
93. D. Papazoglou, G. Galazios, K. Papatheodorou, V. Liberis, N. Papanas, E. Maltezos, and G.B. Maroulis Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss Fertil. Steril. 83 2005 959 963
94. D. Papazoglou, G. Galazios, M.I. Koukourakis, I. Panagopoulos, E.N. Kontomanolis, K. Papatheodorou, and E. Maltezos Vascular endothelial growth factor gene polymorphisms and pre-eclampsia Mol. Hum. Reprod. 10 2004 321 324
95. B. Yang, D.F. Cross, M. Ollerenshaw, B.A. Millward, and A.G. Demaine Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus J. Diabetes Complications 17 2003 1 6
96. C. Salvarani, L. Boiardi, B. Casali, I. Olivieri, F. Cantini, F. Salvi, R. Malatesta, R. La Corte, G. Triolo, A. Ferrante, D. Filippini, G. Paolazzi, P. Sarzi-Puttini, D. Nicoli, E. Farnetti, Q. Chen, and L. Pulsatelli Vascular endothelial growth factor gene polymorphisms in Behcet's disease J. Rheumatol. 31 2004 1785 1789
97. K.T. Ku, L. Wan, H.C. Peng, M.H. Tsai, C.H. Tsai, and F.J. Tsai Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer Oral Oncol. 41 2005 497 502
98. Y.Y. Hsieh, C.C. Chang, F.J. Tsai, L.S. Yeh, C.C. Lin, and C.T. Peng T allele for VEGF gene-460 polymorphism at the 5′-untranslated region: association with a higher susceptibility to endometriosis J. Reprod. Med. 49 2004 468 472
99. D. Ray, M. Mishra, S. Ralph, I. Read, R. Davies, and P. Brenchley Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes Diabetes 53 2004 861 864
100. C.C. Lin, H.C. Wu, F.J. Tsai, H.Y. Chen, and W.C. Chen Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer Urology 62 2003 374 377
101. W.C. Chen, H.Y. Chen, H.C. Wu, M.C. Wu, C.D. Hsu, and F.J. Tsai Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease Urol. Res. 31 2003 218 222
102. P. Van der Meer, R.A. De Boer, H.L. White, G. Van der Steege, A.S. Hall, A.A. Voors, and D.J. Van Veldhuisen The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy J. Card. Fail. 11 2005 279 284
103. S. Hoon Kim, Y. Min Choi, S. Ha Choung, J. Kwan Jun, J. Gu Kim, and S. Yong Moon Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis Hum. Reprod. 20 2005 2904 2908
104. R.C. Holt, S.A. Ralph, N.J. Webb, C.J. Watson, A.G. Clark, P.W. Mathieson, and P.E. Brenchley Steroid-sensitive nephrotic syndrome and vascular endothelial growth factor gene polymorphisms Eur. J. Immunogenet. 30 2003 1 3
105. R.W. Cooke, J.A. Drury, R. Mountford, and D. Clark Genetic polymorphisms and retinopathy of prematurity Invest. Ophthalmol. Visual Sci. 45 2004 1712 1715
106. H.S. Young, A.M. Summers, M. Bhushan, P.E. Brenchley, and C.E. Griffiths Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset J. Invest. Dermatol. 122 2004 209 215
107. D. Papazoglou, G. Galazios, M.I. Koukourakis, E.N. Kontomanolis, and E. Maltezos Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery Acta Obstet. Gynecol. Scand. 83 2004 461 465
108. M. Saito, K. Usuku, Y. Nobuhara, W. Matsumoto, D. Kodama, A.H. Sabouri, S. Izumo, K. Arimura, and M. Osame Serum concentration and genetic polymorphism in the 5′-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals J. Neurol. Sci. 219 2004 157 161
109. K. Morohashi, T. Takada, K. Omori, E. Suzuki, and F. Gejyo Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis Chest 123 2003 1520 1526
110. G. Wolf, R.M. Aigner, G. Schaffler, U. Langsenlehner, W. Renner, H. Samonigg, B. Yazdani-Biuki, and P. Krippl The 936C > T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake Breast Cancer Res. Treat. 88 2004 205 208
111. A.R. Medford, L.J. Keen, J.L. Bidwell, and A.B. Millar Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome Thorax 60 2005 244 248
112. P. Krippl, U. Langsenlehner, W. Renner, B. Yazdani-Biuki, G. Wolf, T.C. Wascher, B. Paulweber, J. Haas, and H. Samonigg A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int. J. Cancer 106 2003 468 471
113. M. Numata, M. Nakayama, T. Hosoya, C.M. Hoff, C.J. Holmes, M. Schalling, L. Nordfors, and B. Lindholm Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients Clin. Nephrol. 62 2004 455 460
114. S. Sakao, K. Tatsumi, T. Hashimoto, H. Igari, Y. Shino, H. Shirasawa, and T. Kuriyama Vascular endothelial growth factor and the risk of smoking-related COPD Chest 124 2003 323 327
115. A. Abe, K. Sato, T. Habuchi, L. Wang, Z. Li, N. Tsuchiya, C. Ohyama, S. Satoh, O. Ogawa, and T. Kato Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma Tohoku J. Exp. Med. 198 2002 181 190
116. Y. Tang, M.L. McKinnon, L.M. Leong, S.A. Rusholme, S. Wang, and R.J. Akhurst Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice Hum. Mol. Genet. 12 2003 1579 1589